SYMPLIFY, a prospective observational study, is the first large-scale evaluation of a multi-cancer early detection (MCED) test in individuals who presented with symptoms to primar ...

My doctor was of the opinion that over-medicalisation of patients was a common problem, and that a high PSA reading might ...

Two cancer experts go head to head, arguing the case for and against a targeted prostate cancer screening programme.

Men with BRCA1 and BRCA2 gene mutations should be given annual prostate cancer screening checks, leading scientists have said. Experts at the Institute of Cancer Research (ICR) in London said men with ...

Fortunately, we found a deal on a two-pack of reliable at-home COVID-19 tests for nearly 43% off right now on Amazon. That’s ...

The former PM is among those in favour of targeted screening for men most at risk, but some medical experts are sceptical.

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...